Global Health, Veeda Clinical receive Sebi approval to launch IPOs
- Date: 27-Dec-2021
- Source: Money Control
- Sector:Healthcare
- Country:Middle East
Global Health, Veeda Clinical receive Sebi approval to launch IPOs
Veeda Clinical Research's Rs 831-crore IPO consists of an issuance of fresh equity shares worth up to Rs 331.60 crore and an OFS of Rs 500 crore by promoters and existing shareholders.
PTI
December 27, 2021 / 08:43 PM IST
Global Health IPO, Veeda Clinical IPO receive Sebi approval
Global Health, which operates and manages hospitals under the Medanta brand, and clinical research organisation Veeda Clinical Research has received markets regulator Sebi's go-ahead to raise funds through an initial public offering (IPO).
These companies, which filed their preliminary IPO with Sebi in September, obtained its observations on December 21, an update with the regulator showed on Monday.
In Sebi parlance, the issuance of observations letter implies its go-ahead for the IPO.
Going by the draft papers, Global Health's IPO consists of a fresh issue of equity shares aggregating to Rs 500 crore, and an offer for sale of up to 4.84 crore equity shares.
Click Here To Read All IPO Related News
As part of the offer-for-sale (OFS), Anant Investments, an affiliate of private equity major Carlyle Group, will sell up to 4.33 crore equity shares and Global Health co-founder Sunil Sachdeva (jointly with Suman